"We know the devil will be in the detail and there is a huge amount of work ahead in negotiating and defining how we implement the reforms that are so urgently needed," said Medicines Australia chief executive and HTA review reference committee member Liz de Somer.
Medicines Australia says the 'devil is in the detail' of HTA review options paper
January 29, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech

